Galapagos Announces Exit from Cell‑Therapy Business After Strategic Review
Galapagos NV (FRA: GXE) today disclosed that it has decided to wind down its cell‑therapy...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity
Galapagos NV (FRA: GXE) today disclosed that it has decided to wind down its cell‑therapy...